Using spinal cord stimulation to treat diabetic peripheral neuropathy
Official title: A Novel Neuromodulation Approach to Target Small Fiber Neuropathy Early in Diabetes and Measure Functional Recovery
Run by Ohio State University · NCT06287736 · Data updated 2026-11-12
This study is testing if spinal cord stimulation can help people with diabetic peripheral neuropathy feel less pain and improve their nerve health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Ohio State University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Columbus, Ohio) |
| Status | Recruiting |
| Started | April 17, 2024 |
| Main results expected | February 1, 2028 |
| Study ends | July 3, 2028 |
| Registry record updated | July 23, 2026 |
| Trial ID | NCT06287736 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old with diabetic peripheral neuropathy that has not responded to standard treatments.
✕Probably not a fit
Patients with severe medical comorbidities or those who cannot undergo surgical intervention may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial is a prospective randomized control trial that aims to evaluate the effectiveness of spinal cord stimulation (SCS) in treating diabetic peripheral neuropathy (DPN). Participants will be randomly assigned to one of three groups: two treatment groups receiving SCS and one control group. The study will measure pain levels, DPN severity, small fiber nerve activity, and metabolic health markers before and after the SCS treatment. The goal is to gather more information on the diagnosis and treatment of DPN using SCS.
Why it matters
Potential benefit: If successful, this study could provide a new effective treatment option for patients suffering from diabetic peripheral neuropathy.
How similar studies have gone: Previous studies have shown that spinal cord stimulation can be effective in treating chronic pain, including diabetic peripheral neuropathy, indicating a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Over 18 years old * Diagnosis of diabetic peripheral neuropathy refractory to treatment with gabapentin or pregabalin and at least 1 other class of analgesic * Diagnosis of medically refractory pain secondary to diabetic neuropathy * Presence of pain for 12 months * Lower limb pain intensity score ≥4 on a visual analog scale * DN4 ≥4 * Pass pre-operative neuropsychological assessment (surgical group only) * Capable of providing informed consent Exclusion Criteria: * Severe medical comorbidities that, in the opinion of the surgeon, exclude the patient from surgical intervention * Spinal disease with severe spinal stenosis or spinal cord compression in the region of the proposed spinal cord stimulator lead placement * Coagulopathy that cannot be corrected * Unable to discontinue blood thinning medications * Hemoglobin A1c level greater than 10 * Presence of systemic infection * Pregnancy
Where it's running
-
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States Recruiting
Study contacts
- Principal investigator: Brian Dalm, MD — Ohio State University
- Study coordinator: Alexander Price
- Email: Alexander.Price2@osumc.edu
- Phone: 614-366-7822
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of perturbation-based balance training vs conventional balance training for reactive stepping in adults with diabetic nerve damage
A 40-person study will test whether adding perturbation-based balance training helps adults with diabetic peripheral neuropathy react better to balance threats compared with standard balance training.
-
Ultrasound-guided nerve hydrodissection for diabetic leg nerves
A single ultrasound-guided nerve hydrodissection procedure is tested to see if it helps people with diabetic lower limb entrapment neuropathy feel less pain and have better nerve function.
-
Shortwave therapy for diabetic peripheral neuropathy
A one-center study will test whether shortwave therapy given for five days can improve nerve symptoms in adults with diabetic neuropathy compared to a sham treatment.
-
MinION sequencing to identify microbes in diabetic foot bone infections
This study will test a rapid MinION DNA sequencing method to identify bacteria, fungi, and resistance genes in infected diabetic foot wounds and compare the results with standard culture.
-
Intraneural Facilitation and Otago Exercise for Diabetic Peripheral Neuropathy
This study will test whether intraneural facilitation, the Otago exercise program, or a combination of both can improve balance, reduce neuropathic pain, and improve quality of life for people aged 50–75 with diabetic peripheral neuropathy.
-
Topical Capsadyn (palmitated capsaicin) for diabetic neuropathic foot pain
This study will test whether a topical Capsadyn cream can reduce foot pain in adults with diabetic peripheral neuropathy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.